Home » Attend

Attend

10th PATIENT CENTRICITY & COLLABORATION WORLD CONGRESS 2027 EUROPE

Patient Partnership as the Engine of Innovation, Equity, and Trust

Millennium Hotel and Conference Centre Gloucester London, UK

Pre - Conference Workshops - Wednesday 24th February 2027

Thursday 25th - Friday 26th February 2027

We are pleased to welcome you to the 10th Patient Centricity and Collaboration World Congress 2027 Europe, hosted by Facilitate Live. Over three days, we aim to foster meaningful collaboration across the healthcare ecosystem, enabling delegates to gain practical strategies and best practices for addressing emerging challenges, embracing innovation, leveraging new technologies, and advancing patient centric goals.

This year’s congress is anchored by the strategic theme, “Patient Partnership as the Engine of Innovation, Equity, and Trust.” It reflects the growing recognition across the healthcare ecosystem that patient involvement is a critical driver of scientific excellence, operational performance, and sustainable innovation.

The Congress convenes leaders from biopharmaceutical organisations, regulatory bodies, clinical research, digital health, and patient advocacy to examine how patient partnership can be embedded more systematically across the development and delivery lifecycle. As healthcare becomes increasingly digital, decentralised, and data‐driven, organisations must adopt models that integrate patient insights into decision‐making, strengthen transparency, and ensure equitable access to research and care.

Achieving patient centricity requires a shift from traditional, organisation‐led approaches toward structured, patient‐centered frameworks. This includes incorporating patient perspectives into early‐stage development, protocol design, endpoint selection, and communication strategies. It also involves adopting personalised care models that tailor treatments, information, and support to individual needs. Clear, accessible communication remains essential to building trust and enabling informed decision‐making across diverse European populations.

Technology plays a pivotal role in advancing this agenda. Decentralised and hybrid trials, digital monitoring, artificial intelligence, and real‐world evidence offer opportunities to reduce burden, improve data quality, and expand participation. However, these innovations also introduce new complexities related to governance, equity, and patient readiness. Organisations must ensure that digital transformation enhances, not hinders the patient experience, and that solutions are designed with inclusivity, transparency, and regulatory alignment. Globally, the industry has made significant progress in operationalising patient centered approaches. Patient centricity has evolved from a conceptual aspiration into a measurable strategic priority supported by frameworks, metrics, and cross‐functional governance. Yet, as healthcare models continue to evolve and patients become more informed and digitally engaged, achieving true patient centricity remains an ongoing commitment requiring continuous improvement and collaboration.

We look forward to your participation in this year’s Congress and to the insights, partnerships, and strategic discussions that will help shape the future of patient‐driven innovation across Europe.

We look forward to meeting you at the Congress!

GAIN LATEST INSIGHTS ON:

  • How patient partnership is becoming a strategic engine for innovation, equity, and trust across European healthcare systems
  • New models of co‐creation that embed patient voice into discovery, development, clinical design, and post‐market decision‐making
  • Ethical, inclusive approaches to AI‐enabled clinical development that strengthen transparency, fairness, and patient confidence
  • The evolution of decentralised and hybrid trials designed around patient convenience, digital readiness, and real world feasibility
  • Human‐centred digital experience design that reduces burden, improves accessibility, and supports diverse patient populations
  • Modern COAs, digital biomarkers, and experience‐driven endpoints that capture what truly matters to patients
  • Behavioural science frameworks that enhance adherence, self‐management, and long‐term engagement across chronic conditions
  • Health literacy strategies that transform complex information into clear, actionable, and culturally relevant communication
  • Community‐driven engagement models that expand representation, build trust, and reach underserved and research‐naïve populations Real world evidence approaches that illuminate patient experience, tolerability, and long term outcomes beyond traditional trials
  • Advanced analytics and predictive modelling that improve feasibility, site selection, operational forecasting, and trial performance
  • Governance structures that ensure responsible, compliant, and patient‐aligned use of digital tools and AI in clinical research
  • Personalised care strategies that tailor treatments, communication, and support to individual patient needs and preferences
  • Cross‐functional operating models that integrate patient insights into enterprise‐wide strategy, culture, and decision‐making
  • The future of patient centric leadership and the capabilities organisations need to thrive in an ethical, digital, inclusive healthcare landscape.

Co-located with the 3rd DCT, Hybrid & Centralised Trials 2027 Europe 

WHO SHOULD ATTEND?

This Congress is beneficial to pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology and healthcare companies.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Leaders in the area of:

Patient Engagement & Patient Centricity

  • President / Head of
  • Patient Engagement
  • Chief Patient Officer
  • VP Patient Centricity
  • Director, Patient Advocacy & Partnerships
  • Head of Patient Experience
  • Global Lead, Patient Insights
  • Director, Patient Diversity & Inclusion

Clinical Development & Clinical Operations

  • Head of Clinical Development
  • VP Clinical Operations
  • Director, Clinical Innovation
  • Head of Decentralised & Hybrid Trials
  • Director, Site Engagement & Trial Enablement
  • VP Early Development & Trial Strategy

Digital Health, AI & Technology

  • Chief Digital Officer
  • VP Digital Health & Innovation
  • Head of AI in Clinical Development
  • Director, Digital Trial Solutions
  • Head of Digital Patient Experience
  • Director, eConsent / eCOA / Digital Platforms

Real‐World Evidence & Data Science

  • VP Real‐World Evidence
  • Head of Real‐World Data & Analytics
  • Director, Patient‐Reported Outcomes
  • Head of Epidemiology & Observational Research
  • Director, Data Strategy & Insights

Medical Affairs & Scientific Strategy

  • VP Medical Affairs
  • Head of Medical Excellence
  • Director, Medical Communications & Education
  • Head of Evidence Generation
  • Director, Scientific Strategy & Innovation

Market Access, Value & Health Economics

  • VP Market Access
  • Head of HEOR
  • Director, Value & Access Strategy
  • Head of Pricing & Reimbursement
  • Director, Patient Value & Outcomes

Experience Design, Behavioural Science &
Communications

  • Head of Patient Experience Design
  • Director, Behavioural Science
  • VP Communications & Patient Information
  • Director, Health Literacy & Plain Language
  • Head of Experience Research & Insights

Quality, Ethics & Governance

  • Chief Ethics & Compliance Officer
  • Head of Patient Safety
  • Director, Clinical Quality & Governance
  • Head of Regulatory Policy & Engagement

Delegate Tickets

Group Discounts Are Also Available

Patients / Patient Group

Subject To Approval
Free
  • Full Access - 2 Day Conference
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.

Non Profit / Acedemic

Verification Required
£499
  • Full Access - 2 Day Conference
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.

Standard Registration Rate

Pharma / Biotech
£1299
  • Full Access - 2 Day Conference
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.

Standard Vendor Registration Rate

Vendors / Service / Solution Providers / Consultants / CRO's
£1999
  • Full Access - 2 Day Conference
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.
Scroll to Top
Update cookies preferences